Welcome to the Academic Year 2020-21 Schedule
Hosted by Liv-TB
Could adjunctive host-directed therapy to modulate damaging immune responses improve outcomes for TB patients? Come to NLTBJC, hosted by Liv-TB, 1st April 2021 at 1pm, to discuss the results of an ambitious study assessing four potential host-directed therapies for TB: auranofin, CC-11050, ergocalciferol and everolimus, in an open label, phase 2 randomised controlled trial in pulmonary TB patients in South Africa (Wallis et al. Lancet Resp Med 2021).
PAPERS: Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial
Chair: Dr Tom Wingfield
PRESENTER: Dr Naomi Walker
DATE: Thursday 1st April, 2021
VENUE: Online – Sign in details:
Please join from your computer, tablet or smartphone.
You can also dial in using your phone.
United Kingdom: +44 20 3713 5028
Access Code: 180-472-637
Hosted by LSHTM
PRESENTER: Dr Stephen Close
DATE: Thursday 29th April, 2021
VENUE: Via Zoom